Zoetis (NYSE:ZTS – Free Report) had its price target reduced by UBS Group from $85.00 to $80.00 in a research report sent to investors on Friday,Benzinga reports. UBS Group currently has a neutral rating on the stock. Other equities analysts have also issued reports about the company. Wall Street Zen lowered Zoetis from a “buy” […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | JPMorgan Chase & Co. Cuts Zoetis (NYSE:ZTS) Price Target to $115.00 | 0 | 12.26 | 10-08-2026 |
| 2 | Keefe, Bruyette & Woods Cuts Zillow Group (NASDAQ:Z) Price Target to $34.00 | 0 | 12.61 | 10-08-2026 |
| 3 | Guggenheim Cuts Zevra Therapeutics (NASDAQ:ZVRA) Price Target to $23.00 | 0 | 9.15 | 10-08-2026 |
| 4 | US Foods (NYSE:USFD) Price Target Raised to $125.00 | 0 | 13.43 | 10-08-2026 |
| 5 | Valaris (NYSE:VAL) Price Target Raised to $80.00 | 0 | 10.77 | 10-08-2026 |
| 6 | US Foods (NYSE:USFD) Price Target Raised to $124.00 | 0 | 13.43 | 10-08-2026 |
| 7 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 8 | AMN Healthcare Services (NYSE:AMN) Price Target Raised to $35.00 | 0 | 10.79 | 10-08-2026 |
| 9 | Modine Manufacturing (NYSE:MOD) Stock Rating Lowered by Wall Street Zen | 0 | 6.97 | 27-07-2026 |